Specialists from the Digestive System Department at Hospital Germans Trias have conducted and published a unique study that represents a significant improvement in the monitoring and treatment of patients who have undergone ...
Feb 27, 2025
0
2
Scarring is expected after most operations, but surgical adhesions present a unique challenge for patients and surgeons. These internal bands of scar tissue can bind organs to each other or to the wall of the abdomen, causing ...
Feb 27, 2025
0
0
Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a study published in the March issue of the International Journal of Cardiology Cardiovascular Risk and ...
Feb 5, 2025
0
1
An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions associated with the inflammation of the eye's iris, also known as anterior uveitis. The research also uncovered ...
Jan 30, 2025
0
2
The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in adults.
Jan 17, 2025
0
0
Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a first-of-its-kind study.
Jan 16, 2025
0
2
Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus's ability to invade human cells. SARS-CoV-2 is the virus that spreads COVID-19.
Jan 14, 2025
0
1
For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months compared with tofacitinib, according to a study published in the December issue of the American Journal ...
Dec 23, 2024
0
0
A simple, non-invasive treatment focused on the ears could one day provide relief for people with ulcerative colitis, a UM research study has found.
Dec 16, 2024
0
1
Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis, are marked by cycles of immune activation and inflammation that significantly impact patients' lives.
Dec 12, 2024
0
0
